CEO of Myos Rens Technology Inc (MYOS, Financial) Joseph Mannello bought 221,774 shares of MYOS on 04/25/2018 at an average price of $1.24 a share. The total cost of this purchase was $275,000.
Myos Rens Technology Inc is engaged in discovery, development and commercialization of nutritional supplements, functional foods, therapeutic products and other technologies aimed at maintaining or improving the health. Myos Rens Technology Inc has a market cap of $8.110 million; its shares were traded at around $1.25 with and P/S ratio of 14.03. Myos Rens Technology Inc had annual average EBITDA growth of 19.10% over the past five years.
CEO Recent Trades:
- CEO Joseph Mannello bought 221,774 shares of MYOS stock on 04/25/2018 at the average price of $1.24. The price of the stock has increased by 0.81% since.
Directors and Officers Recent Trades:
- Director Christopher Pechock bought 80,645 shares of MYOS stock on 04/25/2018 at the average price of $1.24. The price of the stock has increased by 0.81% since.
For the complete insider trading history of MYOS, click here
.
